Regio- and stereoselective hydroxylation of testosterone by cytochrome P450 from Streptomyces griseus ATCC 13273-Reference-Cited by-同舟云学术

Regio- and stereoselective hydroxylation of testosterone by cytochrome P450 from Streptomyces griseus ATCC 13273

Published:2020-08-03 Issue:2 Volume:39 Page:130-137
ISSN:1024-2422
Container-title:Biocatalysis and Biotransformation
language:en
Short-container-title:Biocatalysis and Biotransformation

Author:

Zhu Jinqian¹,Shen Chen¹,Zhao Wanli¹,Liu Xiufeng¹,Liu Jihua¹²,Yu Boyang¹²

Affiliation:

1. Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China

2. State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China

Funder

Major Scientific and Technological Specialized Project for “New Drugs Development”

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

Informa UK Limited

Subject

Biochemistry,Catalysis,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10242422.2020.1799990

Reference19 articles.

1. Hydroxylation of Testosterone by Bacterial Cytochromes P450 Using theEscherichia coliExpression System

2. Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450

3. Tracking Down a New Steroid-Hydroxylating Promiscuous Cytochrome P450: CYP154C8 fromStreptomycessp. W2233-SM

4. Characterization of two steroid hydroxylases from different Streptomyces spp. and their ligand‐bound and ‐unbound crystal structures

5. Effects of Alternative Redox Partners and Oxidizing Agents on CYP154C8 Catalytic Activity and Product Distribution

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbial P450 repertoire (P450ome) and its application feasibility in pharmaceutical industry, chemical industry, and environmental protection;Biotechnology and Bioengineering;2023-09-28

2. Biotechnological application of Streptomyces for the production of clinical drugs and other bioactive molecules;Current Opinion in Biotechnology;2022-10